The relevance of the FGFR pathway in the pathogenesis of ARMS is further confirmed by the identification of a FOXO1-FGFR1 fusion gene as molecular driver in a case of ARMS [36]. This evidence concerns the gene FGFR1 and alveolar rhabdomyosarcoma.